GGH
GCM Grosvenor Holdings Portfolio holdings
AUM
$697M
This Quarter Return
-0.88%
1 Year Return
+24.14%
3 Year Return
+62.93%
5 Year Return
–
10 Year Return
–
AUM
$566M
AUM Growth
+$566M
(+13%)
Cap. Flow
+$97M
Cap. Flow
% of AUM
17.15%
Top 10 Holdings %
Top 10 Hldgs %
82.4%
Holding
19
New
3
Increased
11
Reduced
–
Closed
–
Top Buys
| 1 |
CRH
CRH
|
$19M |
| 2 |
Valvoline
VVV
|
$14.8M |
| 3 |
BRSL
Brightstar Lottery PLC
BRSL
|
$13M |
| 4 |
Global Payments
GPN
|
$8.01M |
| 5 |
Elevance Health
ELV
|
$7.45M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Consumer Discretionary | 57.7% |
| 2 | Industrials | 8.54% |
| 3 | Financials | 7.71% |
| 4 | Healthcare | 6.63% |
| 5 | Communication Services | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Maplebear
CART
$11.4B
| $211M | 37.36% |
9,005,196
| – | – |
|
2
Amazon
AMZN
$2.44T
| $38.1M | 6.74% |
250,794
+5,164
| +2% | +$785K |
|
3
T-Mobile US
TMUS
$284B
| $37.4M | 6.61% |
233,278
+26,728
| +13% | +$4.29M |
|
4
Cheniere Energy
LNG
$53.1B
| $33.9M | 5.99% |
198,431
+42,431
| +27% | +$7.24M |
|
5
AerCap
AER
$22B
| $28.3M | 5% |
380,256
+81,256
| +27% | +$6.04M |
|
6
LPL Financial
LPLA
$29.2B
| $26.9M | 4.76% |
118,304
+13,004
| +12% | +$2.96M |
|
7
Rivian
RIVN
$16.5B
| $24.5M | 4.34% |
1,045,635
| – | – |
|
8
Crown Holdings
CCK
$11.6B
| $24.3M | 4.29% |
263,605
+23,605
| +10% | +$2.17M |
|
|
9
Elevance Health
ELV
$71.8B
| $21.4M | 3.78% |
45,289
+15,789
| +54% | +$7.45M |
|
|
10
Global Payments
GPN
$21.5B
| $20.1M | 3.55% |
158,061
+63,061
| +66% | +$8.01M |
|
11
Kenvue
KVUE
$39.7B
| $19.6M | 3.46% |
908,975
+243,975
| +37% | +$5.25M |
|
|
12
CRH
CRH
$75.9B
| $19M | 3.36% |
+275,000
| New | +$19M |
|
13
HDFC Bank
HDB
$182B
| $16.7M | 2.94% |
248,241
+64,241
| +35% | +$4.31M |
|
|
14
Valvoline
VVV
$4.93B
| $14.8M | 2.62% |
+395,000
| New | +$14.8M |
|
15
Natera
NTRA
$23.1B
| $13.6M | 2.4% |
217,157
+27,157
| +14% | +$1.7M |
|
|
BRSL
16
Brightstar Lottery PLC
BRSL
$3.15B
| $13M | 2.29% |
+473,000
| New | +$13M |
|
17
Fate Therapeutics
FATE
$120M
| $1.85M | 0.33% |
495,916
| – | – |
|
18
ADC Therapeutics
ADCT
$345M
| $682K | 0.12% |
410,888
| – | – |
|
19
Sonder
SOND
$25.6M
| $347K | 0.06% |
102,299
| – | – |
|